Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Drug Safety Solutions and Pharmacovigilance Market by Type (Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc), By Application (Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Drug Safety Solutions and Pharmacovigilance Market by Type (Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc), By Application (Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 168458 3300 Medical Devices & Consumables 377 241 Pages 5 (34)
                                          

The global drug safety solutions and pharmacovigilance market is expected to grow at a CAGR of 6.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing number of clinical trials, growing demand for personalized medicine, and increasing awareness about adverse drug reactions. The global drug safety solutions and pharmacovigilance market is segmented on the basis of type into standard form, customized form, and drug safety solutions; on the basis of application into biotechnology and pharmaceuticals, contract research organization (CROS), hospital, KPO/BPO healthcare institutions; on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) Middle East & Africa (MEA). 2) Increasing number of clinical trials 3) Increasing awareness about adverse drug reactions (ADRs) among healthcare professionals and patients.

Some Of The Growth Factors Of This Market:

  1. Increasing awareness about adverse drug reactions (ADRs) among healthcare professionals and patients is also expected to fuel the growth of this market over the next few years.

Industry Growth Insights published a new data on “Drug Safety Solutions and Pharmacovigilance Market”. The research report is titled “Drug Safety Solutions and Pharmacovigilance Market research by Types (Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc), By Applications (Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others), By Players/Companies Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Drug Safety Solutions and Pharmacovigilance Market Research Report

By Type

Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc

By Application

Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others

By Companies

Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

241

Number of Tables & Figures

169

Customization Available

Yes, the report can be customized as per your need.


Global Drug Safety Solutions and Pharmacovigilance Industry Outlook


Global Drug Safety Solutions and Pharmacovigilance Market Report Segments:

The global Drug Safety Solutions and Pharmacovigilance market is segmented on the basis of:

Types

Standard Form, Customized Form, Drug Safety Solutions and Pharmacovigilanc

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Biotechnology and Pharmaceuticals, Contract Research Organization (CROS), Hospital, KPO / BPO, Healthcare Institutions, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Pharmaceutical Product Development, LLC
  2. Drug Safety Solutions Limited
  3. C3i
  4. Worldwide Clinical Trials
  5. Bioclinica
  6. United Biosource LLC
  7. Ennov
  8. AB Cube
  9. Covance Inc.
  10. Accenture
  11. PRA Health Sciences, Inc.
  12. Ergomed
  13. IQVIA
  14. Genpact
  15. Cognizant
  16. Parexel International Corporation
  17. ArisGlobal
  18. ICON plc
  19. Oracle
  20. Syneos Health
  21. Drug Safety Solutions and Pharmacovigilanc

Global Drug Safety Solutions and Pharmacovigilance Market Overview


Highlights of The Drug Safety Solutions and Pharmacovigilance Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Standard Form
    2. Customized Form
    3. Drug Safety Solutions and Pharmacovigilanc
  1. By Application:

    1. Biotechnology and Pharmaceuticals
    2. Contract Research Organization (CROS)
    3. Hospital
    4. KPO / BPO
    5. Healthcare Institutions
    6. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Drug Safety Solutions and Pharmacovigilance Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Drug Safety Solutions and Pharmacovigilance Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Drug Safety Solutions is a global pharmaceutical safety company. Pharmacovigilance is the practice of monitoring the safety of drugs and other medical products.

Some of the major players in the drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health, Drug Safety Solutions and Pharmacovigilanc.

The drug safety solutions and pharmacovigilance market is expected to register a CAGR of 6.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Drug Safety Solutions and Pharmacovigilance Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Drug Safety Solutions and Pharmacovigilance Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Drug Safety Solutions and Pharmacovigilance Market - Supply Chain
   4.5. Global Drug Safety Solutions and Pharmacovigilance Market Forecast
      4.5.1. Drug Safety Solutions and Pharmacovigilance Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Drug Safety Solutions and Pharmacovigilance Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Drug Safety Solutions and Pharmacovigilance Market Absolute $ Opportunity

5. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      5.3.1. Standard Form
      5.3.2. Customized Form
      5.3.3. Drug Safety Solutions and Pharmacovigilanc
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      6.3.1. Biotechnology and Pharmaceuticals
      6.3.2. Contract Research Organization (CROS)
      6.3.3. Hospital
      6.3.4. KPO / BPO
      6.3.5. Healthcare Institutions
      6.3.6. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026

9. North America Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      9.4.1. Biotechnology and Pharmaceuticals
      9.4.2. Contract Research Organization (CROS)
      9.4.3. Hospital
      9.4.4. KPO / BPO
      9.4.5. Healthcare Institutions
      9.4.6. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      9.7.1. Standard Form
      9.7.2. Customized Form
      9.7.3. Drug Safety Solutions and Pharmacovigilanc
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026

10. Latin America Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      10.4.1. Biotechnology and Pharmaceuticals
      10.4.2. Contract Research Organization (CROS)
      10.4.3. Hospital
      10.4.4. KPO / BPO
      10.4.5. Healthcare Institutions
      10.4.6. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      10.7.1. Standard Form
      10.7.2. Customized Form
      10.7.3. Drug Safety Solutions and Pharmacovigilanc
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Drug Safety Solutions and Pharmacovigilance Demand Share Forecast, 2019-2026

11. Europe Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      11.4.1. Biotechnology and Pharmaceuticals
      11.4.2. Contract Research Organization (CROS)
      11.4.3. Hospital
      11.4.4. KPO / BPO
      11.4.5. Healthcare Institutions
      11.4.6. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      11.7.1. Standard Form
      11.7.2. Customized Form
      11.7.3. Drug Safety Solutions and Pharmacovigilanc
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026

12. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      12.4.1. Biotechnology and Pharmaceuticals
      12.4.2. Contract Research Organization (CROS)
      12.4.3. Hospital
      12.4.4. KPO / BPO
      12.4.5. Healthcare Institutions
      12.4.6. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      12.7.1. Standard Form
      12.7.2. Customized Form
      12.7.3. Drug Safety Solutions and Pharmacovigilanc
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026

13. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Application
      13.4.1. Biotechnology and Pharmaceuticals
      13.4.2. Contract Research Organization (CROS)
      13.4.3. Hospital
      13.4.4. KPO / BPO
      13.4.5. Healthcare Institutions
      13.4.6. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size and Volume Forecast by Type
      13.7.1. Standard Form
      13.7.2. Customized Form
      13.7.3. Drug Safety Solutions and Pharmacovigilanc
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Drug Safety Solutions and Pharmacovigilance Market: Market Share Analysis
   14.2. Drug Safety Solutions and Pharmacovigilance Distributors and Customers
   14.3. Drug Safety Solutions and Pharmacovigilance Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Pharmaceutical Product Development, LLC
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Drug Safety Solutions Limited
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. C3i
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Worldwide Clinical Trials
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Bioclinica
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. United Biosource LLC
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Ennov
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. AB Cube
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Covance Inc.
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Accenture
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. PRA Health Sciences, Inc.
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Ergomed
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. IQVIA
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Genpact
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Cognizant
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Parexel International Corporation
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. ArisGlobal
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. ICON plc
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. Oracle
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. Syneos Health
   &nb

Our Trusted Clients

Contact Us